Ocumetics Technology Corp. OTCFF
0.29 USD +0.01 (+3.14%)
At closeNov 10, 2026, 4:00 PM EST
0.289 Day range 0.289
0.26 52-week range 0.7221
- YTD
- -36.30%
- 1 year
- -61.28%
News
thenewswire.com Ocumetics Announces Changes to Board of Directors; Appoints Sandi Gilbert as Director and Dean Burns as Chairman CALGARY, Alberta - October 29, 2026 – TheNewswire - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce the appointment of Sandi…
thenewswire.com Ocumetics Provides Summary of Group One Patient Clinical Progress Key Highlights Ocumetics is developing an accommodating intraocular lens designed to provide a more natural range of vision, potentially addressing an important limitation of conventional intraocular…
thenewswire.com Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries Key Highlights Group Two clinical study underway - Patient recruitment has begun in Mexico City, with surgeries targeted for Fall 2026 .
thenewswire.com Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries Key Highlights Next-generation Ocumetics Lenses successfully manufactured and ready for the Company's upcoming Group Two first-in-human clinical surgeries in Mexico City.
thenewswire.com Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement Calgary, Alberta – TheNewswire - August 24, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the third…
thenewswire.com Ocumetics Announces Completion of Second Tranche of Unit Private Placement Calgary, Alberta – July 31, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the second…
thenewswire.com Ocumetics Announces Upsizing of Unit Private Placement Calgary, Alberta – TheNewswire - July 30, 2026. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that as a result of strong investor…
thenewswire.com Ocumetics Announces Completion of First Tranche of Unit Private Placement Calgary, Alberta – TheNewswire - July 29, 2026. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the first…
thenewswire.com Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study Key Highlights Positive six-month results from the Company's First-in-Human ("FIH") study support advancement to Group Two clinical surgeries
thenewswire.com Ocumetics Announces Offering of Units Calgary, Alberta – TheNewswire - July 7, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a…
thenewswire.com Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones Key Highlights $1.4 million of debenture principal converted to common shares of Ocumetics
thenewswire.com Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses
thenewswire.com Ocumetics Announces Offering of Units Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a…
thenewswire.com Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life Key Highlights Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements
thenewswire.com Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change Key Highlights No material change: There is no material change in the business affairs of Ocumetics.
thenewswire.com Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting Key Highlights Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.
thenewswire.com Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design Key Highlights Breakthrough Accommodating Interocular Lens Design: The enhanced lens design introduces several novel concepts that are expected to improve substantially upon the consistency,…
thenewswire.com Ocumetics Announces Issuance of Stock Options Calgary, Alberta – March 13, 2026 – TheNewswire - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ”) announces that it has issued 500,000 incentive stock options…
thenewswire.com Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic…
thenewswire.com Ocumetics Announces Appointment of Raymond Marks to Board of Directors Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic…